Stay updated on Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.

Latest updates to the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe record history page shows a new revision label (v3.5.3) replacing the previous v3.5.2, indicating a fresh release of the page's UI and metadata. This is a metadata update rather than a change to study content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry v3.5.2 was added and the previous revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check56 days agoChange DetectedA new Revision: v3.4.3 entry was added to the history, and the previous Revision: v3.4.2 entry was removed.SummaryDifference0.1%

- Check85 days agoChange DetectedA new Revision: v3.4.2 has been added, and earlier entries including a government-funding notice and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check92 days agoChange DetectedAdded an administrative notice about potential processing delays due to a lapse in government funding. Version updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

Stay in the know with updates to Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.